Stock Earnings

Question 1

NovaBay Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, NovaBay Pharmaceuticals Inc'in toplam varlıkları $3 olup, net loss $-8'dir.

Question 2

NBY'ün temel finansal oranları nelerdir?

Accepted Answer

NovaBay Pharmaceuticals Inc'in cari oranı 1, net kâr marjı -88.88, hisse başına satış $2.65'dir.

Question 3

NovaBay Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

NovaBay Pharmaceuticals Inc largest revenue segment is Eyecare & Wound Care, at a revenue of 11,174,000 in the most earnings release.For geography, United States is the primary market for NovaBay Pharmaceuticals Inc, at a revenue of 14,726,000.

Question 4

NovaBay Pharmaceuticals Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre NovaBay Pharmaceuticals Inc'in net loss $-8'dir.

Question 5

NovaBay Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, NovaBay Pharmaceuticals Inc'in yükümlülüğü 3'dir.

Question 6

NovaBay Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

NovaBay Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 4.88'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	9	14	14	8	9
Revenue Growth (YoY)	--	-36%	0%	75%	-11%	50%
Cost of Revenue	--	3	6	6	2	3
Gross Profit	--	6	7	7	5	5
Selling, General & Admin	--	11	12	15	12	12
Research & Development	--	0	0	0	0	0
Operating Expenses	--	11	12	15	12	12
Other Non Operating Income (Expenses)	--	-1	-1	0	-1	0
Pretax Income	--	-7	-9	-10	-5	-11
Income Tax Expense	--	--	--	0	0	0
Net Income	--	-8	-16	-16	-6	-11
Net Income Growth	--	-50%	0%	167%	-45%	10%
Shares Outstanding (Diluted)	--	3.39	0.12	1.61	1.25	1
Shares Change (YoY)	--	2,721%	-93%	28.99%	25%	61%
EPS (Diluted)	--	-2.53	-138.64	-10.1	-5.26	-11.02
EPS Growth	--	-98%	1,273%	92%	-52%	-35%
Free Cash Flow	-7	-5	-3	-6	-9	-4
Free Cash Flow Per Share	--	-1.47	-24.91	-3.72	-7.2	-4
Gross Margin	--	66.66%	50%	50%	62.5%	55.55%
Operating Margin	--	-44.44%	-35.71%	-50%	-75%	-66.66%
Profit Margin	--	-88.88%	-114.28%	-114.28%	-75%	-122.22%
Free Cash Flow Margin	--	-55.55%	-21.42%	-42.85%	-112.5%	-44.44%
EBITDA	--	-4	-5	-7	-6	-6
EBITDA Margin	--	-44.44%	-35.71%	-50%	-75%	-66.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	--	-4	-5	-7	-6	-6
EBIT Margin	--	-44.44%	-35.71%	-50%	-75%	-66.66%
Effective Tax Rate	--	--	--	0%	0%	0%

NovaBay Pharmaceuticals Inc (NBY) Price

NBY Stock Price Chart

NBY Income

Follow-Up Questions